These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 1713809

  • 1. [Activity of 5 alpha-reductase in human hyperplastic prostates].
    Lin Y.
    Zhonghua Yi Xue Za Zhi; 1991 May; 71(5):263-5, 20. PubMed ID: 1713809
    [Abstract] [Full Text] [Related]

  • 2. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M, Bartsch W, Thomsen M, Voigt KD.
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia.
    Weisser H, Tunn S, Behnke B, Krieg M.
    Prostate; 1996 May; 28(5):300-6. PubMed ID: 8610056
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Androgen receptor and 5 alpha-reductase activity in the epithelium and the stroma of human benign prostatic hyperplasia].
    Oishi K, Okada K, Yoshida O, Romijn JC, Bolt de Vries J, Schröder FH.
    Hinyokika Kiyo; 1985 May; 31(5):785-90. PubMed ID: 2413745
    [Abstract] [Full Text] [Related]

  • 11. Potential activities of androgen metabolizing enzymes in human prostate.
    Krieg M, Weisser H, Tunn S.
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):395-400. PubMed ID: 7542902
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia.
    Nassis L, Frauman AG, Ohishi M, Zhuo J, Casley DJ, Johnston CI, Fabiani ME.
    J Pathol; 2001 Dec; 195(5):571-9. PubMed ID: 11745693
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145.
    Durocher Y, Chapdelaine A, Chevalier S.
    Cancer Res; 1989 Sep 01; 49(17):4818-23. PubMed ID: 2474374
    [Abstract] [Full Text] [Related]

  • 18. Stromal 5 alpha-reductase activity is elevated in benign prostatic hyperplasia.
    Wilkin RP, Bruchovsky N, Shnitka TK, Rennie PS, Comeau TL.
    Acta Endocrinol (Copenh); 1980 Jun 01; 94(2):284-8. PubMed ID: 6158242
    [Abstract] [Full Text] [Related]

  • 19. Effects of 5 alpha-reductase inhibition by finasteride on lipoproteins and body composition in males affected by benign prostatic hyperplasia (BPH).
    Denti L, Pasolini G, Cortellini P, Sanfelici L, Benedetti R, Cecchetti A, Ferretti S, Banchini A, Ablondi F, Valenti G.
    J Endocrinol Invest; 1999 Jun 01; 22(10 Suppl):70-1. PubMed ID: 10727053
    [No Abstract] [Full Text] [Related]

  • 20. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y, Ye L, Ding Q, Fang Z, Yao M, Shi D.
    Zhonghua Wai Ke Za Zhi; 2000 Jul 01; 38(7):545-7. PubMed ID: 11832106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.